Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
742,245
+10.7% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. ESPR ranks #43 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 742,245
2026-03-31 670,285
2025-12-31 715,326
2025-09-30 586,424
2025-06-30 617,139
2025-03-31 554,216
2024-12-31 554,216
2024-09-30 554,914
2024-06-30 554,914
2024-03-31 57,991
2023-12-31 57,991
2023-09-30 57,991
2023-03-31 199,811
2022-12-31 196,952
2022-09-30 169,826
2022-06-30 161,815
2022-03-31 152,209
2021-12-31 80,660
2021-09-30 68,083
2021-06-30 190,497
2021-03-31 186,182
2020-12-31 181,288
2020-09-30 178,025
2020-06-30 169,202
2020-03-31 183,731